This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Epigenomics Ag. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Suzanne Mooney: Innovator in Colon Cell Proliferative Disorder Analysis
Introduction
Suzanne Mooney is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of molecular biology, particularly in the analysis of colon cell proliferative disorders. Her innovative work has led to the development of methods and nucleic acids that enhance the detection and differentiation of these disorders.
Latest Patents
Suzanne holds a patent for a method and nucleic acids for the analysis of colon cell proliferative disorders. This patent provides methods and nucleic acids for detecting, differentiating, or distinguishing between colon cell proliferative disorders by analyzing one or more of the genes Versican, TPEF, H-Cadherin, Calcitonin, and EYA4. Additionally, her patent includes novel nucleic acid sequences that are useful for the specific analysis of these genes, along with methods, assays, and kits designed for this purpose. She has 1 patent to her name.
Career Highlights
Suzanne is currently associated with Epigenomics AG, where she continues to advance her research and innovations. Her work is pivotal in the development of diagnostic tools that can significantly impact patient care in the field of oncology.
Collaborations
Some of her notable coworkers include Matthias Burger and Ralf Lesche, who contribute to the collaborative efforts in her research endeavors.
Conclusion
Suzanne Mooney's contributions to the analysis of colon cell proliferative disorders exemplify her dedication to innovation in the field of molecular biology. Her work not only enhances our understanding of these disorders but also paves the way for improved diagnostic methods.